A carregar...

Enhanced oral bioavailability of meptazinol in cirrhosis.

Kinetic analysis was carried out after single intravenous (25 mg) and oral (200 mg) doses of the novel partial opioid agonist meptazinol (Meptid) in patients with non-cirrhotic liver disease (NCLD) and biopsy proven cirrhosis. Comparison was made with a group of patients with normal hepatic function...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Birnie, G G, Thompson, G G, Murray, T, Watkinson, G, Brodie, M J
Formato: Artigo
Idioma:English
Publicado em: 1987
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1432689/
https://ncbi.nlm.nih.gov/pubmed/3570028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!